Date:2/4/2010

at December 31, 2009 and $484 at June 27, 2009 37,433 36,427 Inventories 25,292 28,909 Prepaid expenses and other current assets 8,973 6,186 Deferred cost of revenue-current 15,761 18,984 ------ ------ Total current assets 224,310 192,502 ------- ------- Long-term available-for- sale securities 14,254 35,245 Long-term trading securities - 22,007 Property and equipment, net 12,502 15,066 Goodwill 4,495 4,495 Intangible assets, net 517 668 Deferred cost of revenue-noncurrent 2,817 2,933 Other assets 1,622 1,470 ----- ----- Total assets $260,517 $274,386 ======== ======== Liabilities and stockholders' equity Current liabilities: Accounts payable $11,175 $14,941 Accrued expenses 18,345 15,768 Customer advances-current 13,577 13,185 Deferred revenue-current
'/>"/>

SOURCE Accuray Incorporated Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
8. Accuray Hires General Manager for Japan
9. Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference
10. Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients